Skip to content

Quanterix Corporation QTRX Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT

Other financials

Income statement

See full
Revenue$36.4M+20.1%
Gross profit$15.6M+4.9%
Operating income-$41.4M-56.9%
Net income-$17.5M+14.5%
EPS (diluted)-$0.37+30.2%

Balance sheet

See full
Cash & equivalents$36.2M-52.7%
Total debt$35.3M-2.9%
Total equity$282.1M-10.8%
Total assets$366.7M-7.5%

Cash flow

See full
Operating cash flow-$18.1M-30.4%
CapEx$87.0K-93.1%
Free cash flow-$18.2M-20.1%

Valuation

See full
Market cap$203.97M-20.1%
Enterprise value$203.12M+28.6%
P/S1.4×-0.6×

Profitability

See full
Gross margin44.2%-14.3pp
Operating margin-96.9%-1,691pp
Net margin-71.9%-2,019pp
FCF margin-57.2%-220pp

Returns & leverage

See full
Return on equity-34.8%-122pp
Debt / equity0.1×0.0×
Current ratio3.7×-4.6×

Where this comes from

Reported directly by Quanterix Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: Quanterix Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quanterix Corporation's accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quanterix Corporation's accounts receivable, credit loss expense (reversal)?
Quanterix Corporation (QTRX) reported accounts receivable, credit loss expense (reversal) of $305K in Q1 2026.
How has Quanterix Corporation's accounts receivable, credit loss expense (reversal) changed year-over-year?
Quanterix Corporation's accounts receivable, credit loss expense (reversal) increased by 475.5% year-over-year, from $53K to $305K.
What is the long-term trend for Quanterix Corporation's accounts receivable, credit loss expense (reversal)?
Over 2 years (2022 to 2025), Quanterix Corporation's accounts receivable, credit loss expense (reversal) has grown at a 44.4% compound annual growth rate (CAGR), from -$301K to $628K.